Treatment Options

Unfortunately, there is no cure for IPF but there are ways to manage it

For some patients, depending on their diagnosis, medications may stabilize their disease and there may be a benefit to continuing usage

As with all medicines for any condition, patients should discuss specific treatment options directly with their physician to determine the best approach for their care

While there remains no consistent standard of care for the treatment of IPF, the following medications are commonly prescribed to treat IPF symptoms

Esbriet™ (Pirfenidone)

is an anti-fibrotic / anti‐inflammatory agent and the first and only drug approved specifically for the treatment of mild to moderate IPF in adult patients by Health Canada

Ofev™ (Nintedanib) is an anti-fibrotic drug for the treatment of idiopathic pulmonary fibrosis (IPF).

The other drugs listed below are used by doctors to help manage IPF in patients.

Corticosteroids (Prednisone)

can be used for suppressing or controlling the immune system and inflammation. They can potentially increase the frequency and severity of infections. Individuals receiving prolonged treatment or higher doses need to be carefully monitored

Cyclophosphamide (Cytoxan ®)

is an anti-cancer medication frequently given in conjunction with prednisone or may be given alone

Azathioprine (Imuran ®)

is used to suppress the immune system in autoimmune diseases and prevent the body from rejecting organs following transplantation


There are a number of other treatments to manage IPF.  Speak to your doctor to see which treatment regimen is right for you